Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Motion-graphic videos improve patient understanding more than verbal explanations for platelet-rich plasma therapy.

Injecting CD34+ cell-containing platelet-rich plasma into the scalp can improve hair count and thickness in people with pattern hair loss.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

AI can help track and improve hair loss treatment outcomes.

Presurgical models can effectively and affordably screen cancer prevention agents.

PRP therapy shows promise for healing in kids but needs more research.

The treatment led to denser, thicker hair growth and less hair loss.

A man developed a rare blood vessel connection on his scalp after hair transplants, which was successfully treated with surgery.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

CCCA can affect both genders and all ages, and it has a genetic component.

A rare scalp condition, cutis verticis gyrata, was found in a woman with primary scarring alopecia.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Thorough clinical examination is crucial for diagnosing unusual alopecia.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

Finasteride shows promise for preventing prostate cancer, but more research is needed.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

CEC levels may be a useful marker for predicting prostate cancer progression.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

HPV vaccines are generally safe but need further investigation for rare side effects.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

PRP treatments for hair loss need standard protocols to be reliable.